Early Blood Test Signals Alzheimer's Risk Long Before Scans
A long-term study of cognitively healthy adults found that plasma pTau217 levels forecast early Alzheimer’s pathology and future cognitive decline, often rising years before amyloid PET scans become positive, suggesting blood tests could enable earlier risk detection and screening for prevention trials.
